First Tracks Biotherapeutics, Inc.
- Last sale
- Nov 12, 2026 · -3.59%
- Market cap
- $2.05B
- 42.02M shares
- Filings
- 100
—
—
—Q3 2026
—Q3 2026
—Q3 2026derived
—Q3 2026
—Q3 2026+93.5% FY25 yoy
- $2.05B
- —
- —
- 13.6×
- —
- —
FY2026 figures · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Research And Development
No annual history for this metric yet.
| Period | Ended | Value | Kind | Source trail |
|---|
Pharmaceutical preparations
First Tracks Biotherapeutics, Inc. is the 94th largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
AUPHAurinia Pharmaceuticals Inc.$283.1M20.4%101.5%$2.2BPBHPrestige Consumer Healthcare Inc.$1.1B4.3%17.5%$2.1BVERAVera Therapeutics, Inc.———$2.1B
TRAXFirst Tracks Biotherapeutics, Inc. (this company)———$2.0B
TRVITrevi Therapeutics, Inc.———$2.0BMRVIMaravai Lifesciences Holdings, Inc.$185.7M28.3%70.4%$2.0BSEPNSepterna, Inc.$46.0M4,174.5%106.4%$2.0BHRMYHarmony Biosciences Holdings, Inc.$868.5M21.5%18.3%$2.0BAGIOAgios Pharmaceuticals, Inc.$54.0M48.0%764.0%$1.9BPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
First Tracks Biotherapeutics, Inc. · CIK 2091349 · Engraved from SEC EDGAR